Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • sindrle
    Senior Member
    • Aug 2013
    • 266

    #1

    Cuffdiff time series with two groups

    Hi!
    I have 4 sample groups. Diabetics and healthy at two time point, before and after intervention.

    So, how can I analyse changes in gene expression in the diabetic groups, CONTROLLED for by the healthy group.

    This means I have two discrete groups, but at two timepoint.

    How to tell this to Cuffdiff?

    Thanks!
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    You can't, you'll have to use something else. Cuffdiff is only useful for very basic designs.

    Edit: I should note that you could make the pair-wise comparisons with cuffdiff, but that's not what you want. Give DESeq2/edgeR/limma a try, they're MUCH more flexible.
    Last edited by dpryan; 10-10-2013, 11:46 AM.

    Comment

    • sindrle
      Senior Member
      • Aug 2013
      • 266

      #3
      Wow. Thats a bummer.

      What do you suggest? Im currently testing EdgeR.

      Comment

      • dpryan
        Devon Ryan
        • Jul 2011
        • 3478

        #4
        I'm quite happy with DESeq2. I've used edgeR again recently but have been a bit unhappy with it calling things significant due simply to an outlier sample (DESeq2 flags these on a per-gene basis, though I've also been bitten by this once in a partial knock-out dataset).

        Comment

        • sindrle
          Senior Member
          • Aug 2013
          • 266

          #5
          Ok, sounds like DESeq is the way to go.

          Thanks a lot!

          Im thinking of running Cuffdiff 2.1.1, EdgeR & DEseq. Then compare everything and decide what to use in the publication.

          Comment

          • dpryan
            Devon Ryan
            • Jul 2011
            • 3478

            #6
            Originally posted by sindrle View Post
            Im thinking of running Cuffdiff 2.1.1, EdgeR & DEseq. Then compare everything and decide what to use in the publication.
            I suspect that's a pretty common route people take. Just make sure to validate a few candidates and then base your tool of choice on that rather than simply which gives the bigger list of DE genes!

            Comment

            • sindrle
              Senior Member
              • Aug 2013
              • 266

              #7
              Thanks for the advice!
              Any suggestion on candidates btw? I already have 5 genes tested with qPCR.

              Comment

              • dpryan
                Devon Ryan
                • Jul 2011
                • 3478

                #8
                Try to pick a couple that aren't called DE by all of them. That should help determine which of the models better fit your dataset.

                Comment

                • sindrle
                  Senior Member
                  • Aug 2013
                  • 266

                  #9
                  Thats a great tip!!
                  Thank you.

                  Comment

                  • sindrle
                    Senior Member
                    • Aug 2013
                    • 266

                    #10
                    Can you please guide me on using DEseq2 for this purpose?
                    I dont quite understand how to input:

                    Healthy at baseline, healthy at timepoint 2
                    &
                    Normals at baseline, normals at timepoint 2

                    Comment

                    • dpryan
                      Devon Ryan
                      • Jul 2011
                      • 3478

                      #11
                      Originally posted by sindrle View Post
                      Can you please guide me on using DEseq2 for this purpose?
                      I dont quite understand how to input:

                      Healthy at baseline, healthy at timepoint 2
                      &
                      Normals at baseline, normals at timepoint 2
                      There are two ways one could look at that, I'll just give you one. Suppose you had 8 samples evenly divided into timepoints and normal/healthy groups:

                      Code:
                      status <- factor(c(rep("healthy",4), rep("normal",4)), levels=("normal", "healthy")
                      timepoints <- factor(c(rep(c(1,2), 4)))
                      des <- formula(~timepoints+status)
                      You can then use "des" as the design for your experiment. Alternatively, swap a "*" for the "+" on the last line to include an interaction term, which you probably want.

                      Comment

                      • sindrle
                        Senior Member
                        • Aug 2013
                        • 266

                        #12
                        You are awsome!
                        Some day I hope Ill repay in some way

                        Comment

                        Latest Articles

                        Collapse

                        • SEQadmin2
                          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                          by SEQadmin2






                          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                          Despite this, “CRISPR helped turn genome editing from a specialized
                          ...
                          07-31-2026, 11:01 AM
                        • SEQadmin2
                          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                          by SEQadmin2


                          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                          The systematic characterization of the human proteome has
                          ...
                          07-20-2026, 11:48 AM
                        • SEQadmin2
                          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                          by SEQadmin2



                          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                          ...
                          07-09-2026, 11:10 AM

                        ad_right_rmr

                        Collapse

                        News

                        Collapse

                        Topics Statistics Last Post
                        Started by SEQadmin2, 07-31-2026, 02:55 AM
                        0 responses
                        20 views
                        0 reactions
                        Last Post SEQadmin2  
                        Started by SEQadmin2, 07-24-2026, 12:17 PM
                        0 responses
                        16 views
                        0 reactions
                        Last Post SEQadmin2  
                        Started by SEQadmin2, 07-23-2026, 11:41 AM
                        0 responses
                        16 views
                        0 reactions
                        Last Post SEQadmin2  
                        Started by SEQadmin2, 07-20-2026, 11:10 AM
                        0 responses
                        26 views
                        0 reactions
                        Last Post SEQadmin2  
                        Working...